BTIM will launch 7 new human embryonic progenitor cell lines and 7 novel culture media for these lines on 9/1/10. Read more…
Congress MUST take up the issue of embryonic stem cell research when it reconvenes in September with an urgency to pass legislation.
Cambridge University, UK scientists reprogramed cells from the skin samples into induced pluripotent stem (IPS) cells and then reprogrammed them to generate liver cells Read more…
The Dickey-Wicker Amendment is the name of an appropriation bill rider attached to a bill passed by US Congress in 1995, Read more…
Mayo Clinic researchers have created a new set of laboratory anaplastic thyroid cancer (ATC) cells, derived from tumors donated by patients. Read more…
CUR filed an IND application with the FDA to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. Read more…
The government will quickly appeal a court ruling that undercut federally funded embryonic stem cell research. The Justice Department said an appeal is expected this week Read more…
ACTC.OB commented today on the 8/23/10 federal court ruling, temporarily blocking federal funding for embryonic stem cell research involving the destruction of embryos. Read more…
The White House is reviewing (8/24/10) all options for responding to a court ruling stopping federal funding of human embryonic stem cell research. Read more…
Australian researchers at the University of NSW have found a way to generate stem cells from human skin - known as induced pluripotent stem (iPS) cells – without introducing the risk of troublesome “foreign DNA”. Read more…
Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.